A recent landmark study showed that mRNA containing lipid nanoparticles can be used to potentially develop a “vaccine” for multiple sclerosis using similar technology to the Pfizer and Moderna COVID-19 vaccines. This videos shows data from a study in experimental autoimmune encephalomyelitis, a mouse model of MS.